Xometry, Inc. and Subsidiaries
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except share and per share amounts)
|
Three Months Ended
March 31, | ||||||||
| 2022 | 2021 | |||||||
| (unaudited) | ||||||||
| Revenue | $ | 83,671 | $ | 43,922 | ||||
| Cost of revenue | 50,732 | 34,087 | ||||||
| Gross profit | 32,939 | 9,835 | ||||||
| Sales and marketing | 19,285 | 7,563 | ||||||
| Operations and support | 12,358 | 4,330 | ||||||
| Product development | 7,290 | 3,664 | ||||||
| General and administrative | 12,959 | 4,327 | ||||||
| Total operating expenses | 51,892 | 19,884 | ||||||
| Loss from operations | (18,953 | ) | (10,049 | ) | ||||
| Other (expenses) income | ||||||||
| Interest expense | (769 | ) | (330 | ) | ||||
| Interest and dividend income | 96 | — | ||||||
| Other expenses | (962 | ) | (122 | ) | ||||
| Income from unconsolidated joint venture | 34 | — | ||||||
| Total other expenses | (1,601 | ) | (452 | ) | ||||
| Loss before income taxes | (20,554 | ) | (10,501 | ) | ||||
| Benefit for income taxes | 559 | — | ||||||
| Net loss | (19,995 | ) | (10,501 | ) | ||||
| Net income attributable to noncontrolling interest | 17 | — | ||||||
| Net loss attributable to common stockholders | $ | (20,012 | ) | $ | (10,501 | ) | ||
| Net loss per share, basic and diluted | $ | (0.43 | ) | $ | (1.33 | ) | ||
| Weighted-average number of shares outstanding used to compute net loss per share, basic and diluted | 46,789,585 | 7,924,848 | ||||||
| Comprehensive loss: | ||||||||
| Foreign currency translation | $ | (28 | ) | $ | 30 | |||
| Total other comprehensive (loss) income | (28 | ) | 30 | |||||
| Net loss | (19,995 | ) | (10,501 | ) | ||||
| Comprehensive loss | (20,023 | ) | (10,471 | ) | ||||
| Comprehensive income attributable to noncontrolling interest | 34 | — | ||||||
| Total comprehensive loss attributable to common stockholders | $ | (20,057 | ) | $ | (10,471 | ) | ||
